You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vincristine

Showing 1 - 25 of 1,388
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Cancer Trial in Eldoret (Vincristine)

Recruiting
  • Pediatric Cancer
  • Vincristine
  • Eldoret, Rift Valley, Kenya
    Moi Teaching and Referral Hospital
Apr 25, 2023

Langerhans Cell Histiocytosis Trial in Shanghai (Prednisone+Cytarabine+vincristine,

Recruiting
  • Langerhans Cell Histiocytosis
  • Shanghai, China
    Shanghai Children's Medical Center
Jul 23, 2022

Vincristine-induced Peripheral Neuropathy in Adult Survivors of

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • self-administered questionnaire
  • (no location specified)
Feb 24, 2023

Breast Cancer, Chemo Effect Trial in Beijing (Chidamide)

Recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 17, 2023

Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Rhabdomyosarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Retinoblastoma, Retinal Tumor Trial in Memphis (procedure, drug, radiation, other)

Active, not recruiting
Has Results
  • Retinoblastoma
  • Retinal Neoplasm
  • Enucleation
  • +9 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 10, 2022

Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma Trial in Beijing (Carboplatin, Vincristine, Recombinant human

Recruiting
  • Optic Glioma
  • Pediatric Brain Tumor, Optic Nerve Glioma
  • Beijing, China
    Capital Medical University Sanbo Brain Hospital
Jul 4, 2022

iPSC Neurons From Adult Survivors of Childhood Cancer Who Have

Active, not recruiting
  • Leukemia
  • Lymphoma
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    May 16, 2022

    PI3Kd Inhibitor, Parsaclisib, CHOP Trial (Parsaclisib, CHOP)

    Not yet recruiting
    • PI3Kδ Inhibitor
    • +3 more
    • (no location specified)
    Feb 10, 2022

    Ewing Sarcoma Trial in Beijing (Vincristine, Temozolomide)

    Recruiting
    • Ewing Sarcoma
    • Beijing, Beijing, China
      Peking University People's Hospital
    Oct 31, 2022

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blasts 5 Percent or More of Bone Marrow Nucleated Cells,

    Terminated
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +10 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 17, 2021

    Solid Tumors, Primary Brain Tumors Trial in United States (Vincristine, Irinotecan, Temozolomide)

    Completed
    • Solid Tumors
    • Primary Brain Tumors
    • Vincristine
    • +3 more
    • Hartford, Connecticut
    • +13 more
    Jan 12, 2023

    Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

    Recruiting
    • Neuroblastoma
    • Pediatric Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 11, 2023

    Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)

    Completed
    • Multiple Myeloma and Plasma Cell Neoplasm
    • Buffalo, New York
      Roswell Park Cancer Institute
    Sep 30, 2022

    Treatment-naïve, Peripheral T Cell Lymphoma Trial in Guangzhou (Dose-finding stage: Liposomal mitoxantrone HCl,

    Recruiting
    • Treatment-naïve
    • Peripheral T Cell Lymphoma
    • Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
    • Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jul 26, 2021

    Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5

    Withdrawn
    • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
    • +7 more
    • Inotuzumab Ozogamicin
    • +2 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 13, 2022

    Peripheral T-cell Lymphoma Trial in Tianjin (Lposomal mitoxantrone HCl,Cyclophosphamide,Vincristine,Etoposide and

    Not yet recruiting
    • Peripheral T-cell Lymphoma
    • Lposomal mitoxantrone hydrochloride,Cyclophosphamide,Vincristine,Etoposide and Prednisone(CMOEP)
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Insititute & Hospital
    Jul 13, 2022

    Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)

    Not yet recruiting
    • Solid Tumor
    • Dallas, Texas
      The University of Texas Southwestern Medical Center
    Aug 30, 2022

    Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

    Recruiting
    • Acute Bilineal Leukemia
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)

    Recruiting
    • Primary CNS Lymphoma
    • Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
    • Moscow, Russian Federation
      Nathional Medical Research Center for Hematology
    Jun 16, 2022

    Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)

    Completed
    Has Results
    • Acute Lymphoblastic Leukemia
    • Lymphoblastic Lymphoma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jun 18, 2022

    DLBCL Trial in Cleveland (Loncastuximab tesirine, Prednisone, Rituximab)

    Withdrawn
    • Diffuse Large B-Cell Lymphoma
    • Loncastuximab tesirine
    • +5 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    Mar 15, 2022

    Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Grade IIIb Trial in Guangzhou (Toripalimab,

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • +5 more
    • Toripalimab, Rituximab
    • R-CHOP Protocol
    • Guangzhou, Guangdong, China
      Department of hematology department, Nanfang hospital
    Apr 6, 2022

    B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

    Withdrawn
    • B-cell Acute Lymphoblastic Leukemia
    • Tampa, Florida
    • +2 more
    Feb 14, 2022

    Diffuse Large B Cell Lymphoma Trial (Rituximab, Cyclophosphamide, Doxorubicin)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • (no location specified)
    Apr 24, 2022